JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand flag Thailand · Delayed Price · Currency is THB
1.960
-0.120 (-5.77%)
Mar 2, 2026, 4:35 PM ICT

Revenue by Segment

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Service, Research and Development, and Healthcare Products Training
8.04M7.74M29.19M--
Service, Research and Development, and Healthcare Products Training Growth
3.85%-73.48%---
Manufacture and Distribution of Products under The Company's Brand Name (Own Brands)
337.20M192.74M168.91M139.95M182.77M
Manufacture and Distribution of Products under The Company's Brand Name (Own Brands) Growth
74.95%14.10%20.69%-23.43%115.32%
Manufacture and Distribution of Products under Customer's Brand Name (OEM)
308.39M288.49M249.38M274.20M249.29M
Manufacture and Distribution of Products under Customer's Brand Name (OEM) Growth
6.90%15.68%-9.05%9.99%-9.61%
Other Segments
30.84M21.95M10.60M8.19M23.58M
Other Segments Growth
40.50%107.14%29.33%-65.26%-
Manufacture and Distribution of Hemodialysis Solution and Related Medical Supplies
140.03M64.67M---
Manufacture and Distribution of Hemodialysis Solution and Related Medical Supplies Growth
116.54%----
Unallocated Revenues
21.45M18.78M8.73M6.79M7.10M
Unallocated Revenues Growth
14.20%115.12%28.67%-4.42%-18.96%
Total
845.93M594.36M466.81M429.13M462.74M
Total Growth
42.33%27.32%8.78%-7.26%25.25%

Revenue by Geography

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Thailand
845.93M594.36M466.80M429.13M462.74M
Thailand Growth
42.33%27.32%8.78%-7.26%25.25%
Total
845.93M594.36M466.80M429.13M462.74M
Total Growth
42.33%27.32%8.78%-7.26%25.25%
Source: S&P Global Market Intelligence.